1 active not recruiting, 1 completed, 1 recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Locally Advanced Lung Carcinoma: new trials by email Literature Review of Locally Advanced Lung Carcinoma trials Research Report on Locally Advanced Lung Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cadonilimab(AK104) Plus Concurrent Chemoradiotherapy in Patients With Locally Advanced, Unresectable, Stage III NSCLC Cadonilimab (AK104) - NSCLC, Locally Advanced Lung Carcinoma | Phase 2 | Active not recruiting | Fudan University | 41 | 2024-07-01 | 2025-09-24 |
| Esomeprazole and Radiation Induced Esophagitis Esomeprazole 40 mg - Radiation Esophagitis, Locally Advanced Lung Carcinoma | Phase 2 | Recruiting | Rush University Medical Center | 48 | 2024-03-01 | 2026-08-14 |
| Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer Porfimer Sodium, Ultrasound-Guided Transbronchial Needle-Delivered Interstitial Photodynamic Therapy - Locally Advanced Lung Carcinoma, Non-Small Cell Lung Carcinoma | Phase 1 / Phase 2 | Completed | Roswell Park Cancer Institute | 19 | 2020-02-12 | 2026-05-14 |
Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1) · Small Cell Lung Carcinoma (1)
Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Lung Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
Chemoradiotherapy (1) · Dihematoporphyrin Ether (1) · Esomeprazole (1)
Fudan University (1) · Roswell Park Cancer Institute (1) · Rush University Medical Center (1)
United States (2) · China (1)
Nathaniel Ivanick, MD (1) · Soumyajit M Roy, PhD (1)
R44CA265656 (1)